CONDENSED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Revenue	$ 9,694	$ 8,109	$ 29,283	$ 27,342
Operating expenses:
Cost of revenue		405		1,408
Research and development	22,318	17,884	63,802	53,104
General and administrative	8,934	6,215	24,769	17,780
Total operating expenses	31,252	24,504	88,571	72,292
Loss from operations	(21,558)	(16,395)	(59,288)	(44,950)
Other income (expense):
Change in fair value of warrant liability	12,773	(9,272)	20,819	11,035
Interest and dividend income	60	58	78	497
Other income (expense)	0	(13)	0	482
Net loss	(8,725)	(25,622)	(38,391)	(32,936)
Net loss:
Basic	(8,725)	(25,622)	(38,391)	(32,936)
Diluted	$ (8,725)	$ (25,622)	$ (46,437)	$ (53,243)
Net loss per share:
Basic	$ (0.07)	$ (0.23)	$ (0.32)	$ (0.29)
Diluted	$ (0.07)	$ (0.23)	$ (0.38)	$ (0.47)
Shares used in computing net loss per share:
Basic	133,056	112,557	121,591	112,505
Diluted	133,056	112,557	122,482	113,991